WeSearch

Behind the Mission to Stop Viral Outbreaks Within 100 Days

Veronique Greenwood· ·4 min read · 0 reactions · 0 comments · 44 views
Behind the Mission to Stop Viral Outbreaks Within 100 Days
TL;DR · WeSearch summary

The Coalition for Epidemic Preparedness Innovations (CEPI) is working to prepare for future viral outbreaks by aiming to develop vaccines within 100 days of identifying a new pathogen. Current outbreaks, including hantavirus and Ebola, highlight the urgent need for improved global health preparedness. CEPI estimates that $2.5 billion is necessary to build the infrastructure required to respond effectively to future pandemics.

Key facts
About this source

TIME — Top files mainly under news. We currently carry 213 of its stories.

Original article
TIME — Top · Veronique Greenwood
Read full at TIME — Top →

Story provenance

Source · retrieval · rights · ranking — open for full record
inspect →

Attribution is not the same as permission. This drawer separates discovery metadata, excerpts, WeSearch-generated summaries, reuse status, and whether the publisher receives the visit. Nothing here claims a legal grant the publisher has not made.

Record

Original publisherTIME — Top
Canonical URLhttps://time.com/article/2026/05/19/cepi-mission-to-stop-viral-outbreaks-within-100-days/
Publication timeTue, 19 May 2026 16:57:43 +0000
Retrieval time2026-05-19T17:09:57.873Z
Last seen2026-05-19T17:09:57.873Z
Headline sourcePublisher (no WeSearch rewrite)
Excerpt sourcepublisher body
Excerpt methodFirst ~120 words (~800 chars) of extracted publisher body, fair-use limited.
SummaryWeSearch · cerebras-chat (WeSearch summarizer)
Summary source textcontentText
Citation coverageSummary is a WeSearch-generated derivative; primary citation is the original publisher URL.
ClusterXjQno1nd8aMo
Cluster logicGrouped by semantic title/content similarity across sources within a rolling window. Same-publisher template collisions are excluded from coverage comparison.
Ranking reasonStory pages are not engagement-ranked. Hub feeds use recency, with optional source-diversified chronological ordering (cap consecutive stories per source). No personalized ranking.
Publisher visitYes — open original
Substitutes article?No — link-out required for full text

Rights status (four layers)

Publisher-declared
No publisher-confirmed rights record for this source yet.
Machine-readable
No source-specific machine-readable restriction detected beyond the public feed.
WeSearch interpretation
WeSearch declared handling (basis: Derived from the published RSS/Atom feed). This is WeSearch policy, not a legal grant on the publisher's behalf.
Unknown
Retrieval and training permissions are not asserted unless the publisher confirms them.

WeSearch handling by dimension

Indexing May the item be indexed (stored, ranked, made findable)? Allowed
Snippet May a short excerpt of the publisher's text be shown? Allowed
AI summary May WeSearch generate its own short summary of the article? Limited
Retrieval / RAG May the content be exposed for third-party retrieval-augmented generation? Not asserted
Model training May the content be used to train AI models? Not asserted
Commercial reuse May the content be reused commercially? Not permitted

Basis: Derived from the published RSS/Atom feed. Contact: [email protected]. Reviewed: 2026-07-24.

Opening excerpt (first ~120 words) tap to expand

There are at least two major viral outbreaks underway in the world right now: the Andes hantavirus outbreak that began on a cruise ship and now involves people from more than 20 countries, and the Ebola Bundibugyo outbreak in Democratic Republic of Congo (DRC), which was only very recently announced but which has already killed 131 people and crossed at least one border. No vaccines exist yet for either of these rare strains of already rare diseases.The world is underprepared for threats that are already here, global-health experts argue.

Excerpt limited to ~120 words for fair-use compliance. The full article is at TIME — Top.

Anonymous · no account needed
Share 𝕏 Facebook Reddit LinkedIn Threads WhatsApp Bluesky Mastodon Email

Discussion

0 comments

More from TIME — Top